S-MAC CO., Ltd. acquired an additional 17.2% stake in Kumho HT, Inc. from Lumimicro Co., Ltd for KRW 20.6 billion.
January 07, 2020
Share
S-MAC CO., Ltd. (KOSDAQ:A097780) agreed to acquire an additional 17.2% stake in Kumho HT, Inc. (KOSE:A214330) from Lumimicro Co., Ltd (KOSDAQ:A082800) for KRW 20.6 billion on December 26, 2019. As per terms, KRW 4.1 paid as down payment on December 26, 2019 and the remaining KRW 16.5 billion paid on January 6, 2020. Upon completion of the transaction, S-MAC CO., Ltd. increased its stake in Kumho HT, Inc. from 8.3% to 25.4%. The transaction will be financed from reserved funds of S-MAC CO., Ltd.
S-MAC CO., Ltd. (KOSDAQ:A097780) completed the acquisition of an additional 17.2% stake in Kumho HT, Inc. (KOSE:A214330) from Lumimicro Co., Ltd (KOSDAQ:A082800) on January 6, 2020.
Vivozon Pharmaceutical Co Ltd , formerly Vivozon Healthcare Inc, is a Korea-based company mainly engaged in the manufacture and sale of finished pharmaceutical products. The Company operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
VIVOZON PHARMACEUTICAL CO., LTD. 
